Skip to main content

Peer Review reports

From: Quality of life analyses in patients with multiple myeloma: results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study

Original Submission
13 Nov 2020 Submitted Original manuscript
14 Mar 2021 Reviewed Reviewer Report
16 Mar 2021 Reviewed Reviewer Report
25 Mar 2021 Reviewed Reviewer Report
16 Apr 2021 Author responded Author comments - Gabriel Tremblay
Resubmission - Version 2
16 Apr 2021 Submitted Manuscript version 2
19 Apr 2021 Reviewed Reviewer Report
27 May 2021 Author responded Author comments - Gabriel Tremblay
Resubmission - Version 3
27 May 2021 Submitted Manuscript version 3
Publishing
7 Jun 2021 Editorially accepted
6 Sep 2021 Article published 10.1186/s12885-021-08453-9

You can find further information about peer review here.

Back to article page